Company Overview of T3 Pharmaceuticals AG
T3 Pharmaceuticals AG, a biopharmaceutical company, engages in the research and development of bacteria-based cancer therapies for cancer patients. The company was founded in 2015 and is headquartered in Basel, Switzerland.
Founded in 2015
41 61 267 20 74
Key Executives for T3 Pharmaceuticals AG
Similar Private Companies By Industry
|AB2 Bio Ltd.||Europe|
|ADC Products Switzerland SARL||Europe|
|ADC Therapeutics SA||Europe|
|AlloCyte Pharmaceuticals AG||Europe|
Recent Private Companies Transactions
November 23, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact T3 Pharmaceuticals AG, please visit www.t3pharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.